NEW YORK — The US Food and Drug Administration last week granted separate Emergency Use Authorizations for a PCR-based SARS-CoV-2 test developed by Cepheid and a serology test for the virus from Roche.
The FDA also last week reissued an EUA for Quest Diagnostics RC SARS-CoV-2 Assay to permit its use with pooled samples.